These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
865 related articles for article (PubMed ID: 28391404)
1. Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women. Dallmann A; Ince I; Solodenko J; Meyer M; Willmann S; Eissing T; Hempel G Clin Pharmacokinet; 2017 Dec; 56(12):1525-1541. PubMed ID: 28391404 [TBL] [Abstract][Full Text] [Related]
2. Preliminary physiologically based pharmacokinetic modeling of renally cleared drugs in Chinese pregnant women. Song L; Yu Z; Xu Y; Li X; Liu X; Liu D; Zhou T Biopharm Drug Dispos; 2020 Jun; 41(6):248-267. PubMed ID: 32520400 [TBL] [Abstract][Full Text] [Related]
3. PBPK Modeling Approach to Predict the Behavior of Drugs Cleared by Kidney in Pregnant Subjects and Fetus. Szeto KX; Le Merdy M; Dupont B; Bolger MB; Lukacova V AAPS J; 2021 Jun; 23(4):89. PubMed ID: 34169370 [TBL] [Abstract][Full Text] [Related]
4. Prediction of Maternal and Fetoplacental Concentrations of Cefazolin, Cefuroxime, and Amoxicillin during Pregnancy Using Bottom-Up Physiologically Based Pharmacokinetic Models. Abduljalil K; Ning J; Pansari A; Pan X; Jamei M Drug Metab Dispos; 2022 Apr; 50(4):386-400. PubMed ID: 35046066 [TBL] [Abstract][Full Text] [Related]
5. A Physiologically Based Pharmacokinetic Model for Pregnant Women to Predict the Pharmacokinetics of Drugs Metabolized Via Several Enzymatic Pathways. Dallmann A; Ince I; Coboeken K; Eissing T; Hempel G Clin Pharmacokinet; 2018 Jun; 57(6):749-768. PubMed ID: 28924743 [TBL] [Abstract][Full Text] [Related]
6. Physiologically-based pharmacokinetic modeling of renally excreted antiretroviral drugs in pregnant women. De Sousa Mendes M; Hirt D; Urien S; Valade E; Bouazza N; Foissac F; Blanche S; Treluyer JM; Benaboud S Br J Clin Pharmacol; 2015 Nov; 80(5):1031-41. PubMed ID: 26011128 [TBL] [Abstract][Full Text] [Related]
7. Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir. Liu XI; Momper JD; Rakhmanina N; van den Anker JN; Green DJ; Burckart GJ; Best BM; Mirochnick M; Capparelli EV; Dallmann A J Clin Pharmacol; 2020 Feb; 60(2):240-255. PubMed ID: 31489678 [TBL] [Abstract][Full Text] [Related]
8. Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals. Schlender JF; Meyer M; Thelen K; Krauss M; Willmann S; Eissing T; Jaehde U Clin Pharmacokinet; 2016 Dec; 55(12):1573-1589. PubMed ID: 27351180 [TBL] [Abstract][Full Text] [Related]
9. Physiologically-Based Pharmacokinetic Modeling of Tenofovir Disoproxil Fumarate in Pregnant Women. Zhang X; Luo T; Yang H; Ma WY; He Q; Xu M; Yang Y Curr Drug Metab; 2023; 23(14):1115-1123. PubMed ID: 36718061 [TBL] [Abstract][Full Text] [Related]
10. Application of a Physiologically Based Pharmacokinetic Model to Predict Cefazolin and Cefuroxime Disposition in Obese Pregnant Women Undergoing Caesarean Section. Alrammaal HH; Abduljalil K; Hodgetts Morton V; Morris RK; Marriott JF; Chong HP; Batchelor HK Pharmaceutics; 2022 May; 14(6):. PubMed ID: 35745736 [TBL] [Abstract][Full Text] [Related]
11. Development of a Generic Fetal Physiologically Based Pharmacokinetic Model and Prediction of Human Maternal and Fetal Organ Concentrations of Cefuroxime. Liu XI; Green DJ; van den Anker J; Ahmadzia HK; Burckart GJ; Dallmann A Clin Pharmacokinet; 2024 Jan; 63(1):69-78. PubMed ID: 37962827 [TBL] [Abstract][Full Text] [Related]
12. The Use of Pregnancy Physiologically Based Pharmacokinetic Modeling for Renally Cleared Drugs. Coppola P; Kerwash E; Cole S J Clin Pharmacol; 2022 Sep; 62 Suppl 1():S129-S139. PubMed ID: 36106785 [TBL] [Abstract][Full Text] [Related]
13. Clinical Pharmacokinetic Studies in Pregnant Women and the Relevance of Pharmacometric Tools. Dallmann A; Mian P; Van den Anker J; Allegaert K Curr Pharm Des; 2019; 25(5):483-495. PubMed ID: 30894099 [TBL] [Abstract][Full Text] [Related]
14. Drug Dosing in Pregnant Women: Challenges and Opportunities in Using Physiologically Based Pharmacokinetic Modeling and Simulations. Ke AB; Greupink R; Abduljalil K CPT Pharmacometrics Syst Pharmacol; 2018 Feb; 7(2):103-110. PubMed ID: 29349870 [TBL] [Abstract][Full Text] [Related]
15. Optimization of Drugs Pharmacotherapy During Pregnancy Using Physiologically Based Pharmacokinetic Models - An Update. Alsmadi MM; Idkaidek N Curr Drug Metab; 2018; 19(12):972-978. PubMed ID: 29962340 [TBL] [Abstract][Full Text] [Related]
18. Prediction of Pregnancy-Induced Changes in Secretory and Total Renal Clearance of Drugs Transported by Organic Anion Transporters. Peng J; Ladumor MK; Unadkat JD Drug Metab Dispos; 2021 Oct; 49(10):929-937. PubMed ID: 34315779 [TBL] [Abstract][Full Text] [Related]
19. A simplified PBPK modeling approach for prediction of pharmacokinetics of four primarily renally excreted and CYP3A metabolized compounds during pregnancy. Xia B; Heimbach T; Gollen R; Nanavati C; He H AAPS J; 2013 Oct; 15(4):1012-24. PubMed ID: 23835676 [TBL] [Abstract][Full Text] [Related]
20. PBPK Modeling of the Effect of Reduced Kidney Function on the Pharmacokinetics of Drugs Excreted Renally by Organic Anion Transporters. Hsueh CH; Hsu V; Zhao P; Zhang L; Giacomini KM; Huang SM Clin Pharmacol Ther; 2018 Mar; 103(3):485-492. PubMed ID: 28738449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]